CINGW Cingulate Inc. - Warrants
NASDAQ · SEC EDGAR'da Görüntüle ↗ kapat Eyl 30, 2026 10-K/10-Q Ağu 13, 2026
$0,01
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,0152 haftanın en düşüğü
$0,0652 haftanın en yükseği
Piyasa Değeri (MRQ)
$70.9K
Hisse Başına Kâr
$-4.44
rozetleriniz
52 Haftlık Aralık
$0–$0
Analist Derecelendirmesi
·
Fiyat Hedefi
·
P/E
·
ROE
-559.8%
Net Kâr Marjı
1649.4%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CINGW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.01
Piyasa Değeri (MRQ)
$70.9K
Hisse Başına Kâr
$-4.44
ROE
-559.8%
D/E Borç/Özsermaye (MRQ)
0.2
52 Haftlık Aralık
$0–$0
CINGW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-4.442022-12-31 → 2025-12-31
Serbest Nakit Akışı$-17M2021-12-31 → 2025-12-31
Net kar marjı1649.4%2025-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CINGW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| F/D (MRQ) | 0.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CINGW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | 1464.8% | · | · | · | |
| EBITDA Margin (FAVÖK Marjı) | 1464.8% | · | · | · | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | 1649.4% | · | · | · | |
| Net Profit Margin (Net Kâr Marjı) | 1649.4% | · | · | · | |
| ROA | -150.0%5Y ort. ≈-176.6% | ≈-176.6% | · | · | |
| ROE | -559.8%5Y ort. ≈-101.1% | ≈-101.1% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CINGW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.25Y ort. ≈0.9 | ≈0.9 | · | · | |
| Cari Oran (MRQ) | 3.55Y ort. ≈4.2 | ≈4.2 | · | · | |
| Quick Ratio (Cari Oran) | 1.15Y ort. ≈3.7 | ≈3.7 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CINGW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | -0.1 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $15M | $9M | $8M | $5M | |
| SG&A Expense | $10M | $6M | $7M | $9M | $12M | $2M | |
| Operating Income | $-20M | $-16M | $-23M | $-18M | $-21M | $-7M | |
| Interest Expense | · | · | $790.0K | $292.3K | · | · | |
| Other Non-op | · | $99.2K | $-775.8K | $-174.5K | $-30.6K | $-100.3K | |
| Pretax Income | $-22M | $-17M | $-24M | $-18M | $-21M | $-7M | |
| Net Income | $-22M | $-17M | $-24M | $-18M | $-21M | $-7M | |
| EPS (Basic) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | $-2.79 | · | |
| EPS (Diluted) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · | · | |
| Shares (Basic) | 5,055,329 | 1,524,797 | 75,435 | 602,340 | 7,413,579 | · | |
| Shares (Diluted) | 5,055,329 | 1,524,797 | 75,435 | 602,340 | · | · | |
| EBITDA | $-20M | $-16M | $-23M | $-18M | $-21M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $12M | $52.4K | $5M | $16M | $1M | |
| Short-term Investments | · | · | · | · | $933 | $933 | |
| Receivables | · | · | $14.6K | · | · | · | |
| Prepaid Expense | $1M | $423.2K | $511.6K | $2M | $2M | $439.5K | |
| Current Assets | $12M | $13M | $578.6K | $8M | $19M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $957.7K | |
| Total Assets | $15M | $15M | $3M | $11M | $23M | $6M | |
| Accounts Payable | $2M | $1M | $5M | $762.4K | $264.7K | $975.1K | |
| Accrued Liabilities | $2M | $1M | $2M | $894.6K | $601.3K | $1M | |
| Short-term Debt | $6M | $3M | $3M | $5M | · | $500.3K | |
| Current Liabilities | $10M | $5M | $10M | $7M | $1M | $3M | |
| Capital Leases | $1M | · | $130.7K | $488.7K | $828.5K | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | $23.6K | |
| Total Liabilities | $13M | $7M | $10M | $8M | $2M | $4M | |
| Total Debt | $6M | $3M | $3M | $5M | · | · | |
| Common Stock | $725 | $340 | $10 | $61 | $1.1K | · | |
| Paid-in Capital | $135M | $117M | $86M | $73M | $73M | · | |
| Retained Earnings | $-132M | $-110M | $-93M | $-69M | $-52M | $-31M | |
| AOCI | · | · | · | · | $165 | $165 | |
| Stockholders' Equity | $3M | $7M | $-7M | $4M | $21M | $1M | |
| Liabilities + Equity | $15M | $15M | $3M | $11M | $23M | $6M | |
| Shares Outstanding | 7,250,299 | 3,402,306 | 97,293 | 602,640 | 11,309,412 | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $995.5K | $812.7K | $800.8K | $43.8K | · | |
| Deferred Tax | · | · | · | $0 | $0 | · | |
| Operating Cash Flow | $-17M | $-18M | $-15M | $-16M | $-10M | $-7M | |
| CapEx | $162.1K | $211.8K | $224.1K | $153.4K | $814.7K | $402.1K | |
| Investing Cash Flow | $-162.1K | $-211.8K | $-224.1K | $-152.7K | $-814.7K | $-384.2K | |
| Stock Issued | $10M | $26M | $7M | · | $20M | · | |
| Net Stock Activity | $10M | $26M | $7M | · | $20M | · | |
| Financing Cash Flow | $16M | $31M | $10M | $5M | $27M | $8M | |
| Net Change in Cash | $-1M | $12M | $-5M | $-11M | $15M | · | |
| Free Cash Flow | $-17M | $-19M | $-15M | $-16M | $-11M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | 1464.8% | · | · | · | · | · | |
| Net Margin | 1649.4% | · | · | · | · | · | |
| Pretax Margin | 1649.4% | · | · | · | · | · | |
| EBITDA Margin | 1464.8% | · | · | · | · | · | |
| ROA | -150.0% | -169.4% | -316.0% | -103.1% | -144.4% | · | |
| ROE | -559.8% | -159.5% | 675.7% | -288.6% | -173.1% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.5 | 0.1 | 1.1 | 16.0 | · | |
| Quick Ratio | 1.1 | 2.5 | 0.0 | 0.8 | 14.0 | · | |
| Debt / Equity | 2.5 | 0.3 | -0.4 | 1.3 | · | · | |
| Interest Coverage | · | · | -28.8 | -59.9 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.1 | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $2.19 | $-5.88 | $0.34 | $1.84 | · | |
| Revenue / Share | $-0.27 | · | · | · | · | · | |
| Cash Flow / Share | $-3.41 | $-12.10 | $-16.61 | · | · | · | |
| Cash / Share | $1.51 | $3.59 | $0.04 | $0.47 | $1.46 | · | |
| EPS (TTM) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-1M | $99.2K | · | · | · | · | |
| Net Income TTM | $-22M | $-17M | $-24M | $-18M | $-21M | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $2M | $3M | $3M | $2M | $4M | $1M | $2M | $2M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $4M | $3M | $2M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Operating Income | $-5M | $-6M | $-6M | $-5M | $-4M | $-6M | $-3M | $-3M | $-3M | $-7M | $-6M | $-6M | $-4M | $-4M | $-4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $31.2K | · | $237.5K | $252.5K | $187.5K | $187.5K | $104.8K | · | |
| Interest Income | · | · | · | $93.0K | · | · | · | $2.2K | · | · | · | · | · | · | · | · | |
| Other Non-op | · | · | $-573.1K | $-138.8K | $-96.7K | · | $50.5K | $-3.5K | $-24.3K | $-137.5K | $-229.4K | $-253.9K | $-154.9K | $-129.8K | $-58.9K | $8.4K | |
| Pretax Income | $-6M | $-7M | $-7M | $-5M | $-4M | $-6M | $-4M | $-3M | $-3M | $-7M | $-6M | $-7M | $-4M | $-5M | $-4M | $-4M | |
| Net Income | $-6M | $-6M | $-7M | $-5M | $-4M | $-6M | $-4M | $-3M | $-3M | $-7M | $-6M | $-7M | $-4M | $-5M | $-4M | $-4M | |
| EPS (Basic) | $-0.45 | $-0.96 | $-1.35 | $-1.14 | $-1.04 | $4.16 | $-2.34 | $-5.47 | $-7.21 | $-231.74 | $-72.60 | $-0.57 | $-7.08 | $-28.19 | $-0.36 | $-0.36 | |
| EPS (Diluted) | $-0.45 | $-0.96 | $-1.35 | $-1.14 | $-1.04 | $4.16 | $-2.34 | $-5.47 | $-7.21 | $-225.52 | $-72.60 | $-6.79 | $-7.08 | $-28.19 | $-0.36 | $-0.36 | |
| Shares (Basic) | 13,186,057 | · | 5,431,206 | 4,389,465 | 3,646,893 | · | 1,766,362 | 586,313 | 412,126 | · | 82,361 | 11,694,823 | 565,471 | · | 11,309,412 | 11,309,412 | |
| Shares (Diluted) | 13,186,057 | · | 5,431,206 | 4,389,465 | 3,646,893 | · | 1,766,362 | 586,313 | 412,126 | · | 82,361 | 974,569 | 565,471 | · | 11,309,412 | 11,309,412 | |
| EBITDA | $-5M | · | $-6M | $-5M | $-4M | · | $-3M | $-3M | $-3M | · | $-6M | $-6M | $-4M | · | $-4M | $-4M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $11M | $6M | $9M | $10M | $12M | $10M | $380.9K | $1M | $52.4K | $2M | $349.8K | $2M | $5M | $10M | $8M | |
| Receivables | · | · | · | · | · | · | $2.2K | $2M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $944.4K | $423.2K | $1M | $518.2K | $2M | $511.6K | $910.3K | $2M | $2M | $2M | $2M | $2M | |
| Current Assets | $30M | $12M | $7M | $10M | $11M | $13M | $11M | $3M | $3M | $578.6K | $3M | $2M | $4M | $8M | $12M | $10M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $33M | $15M | $11M | $13M | $12M | $15M | $14M | $5M | $5M | $3M | $6M | $5M | $7M | $11M | $15M | $14M | |
| Accounts Payable | $2M | $2M | $866.2K | $872.9K | $855.1K | $1M | $906.2K | $1M | $737.9K | $5M | $2M | $2M | $599.0K | $762.4K | $392.8K | $282.3K | |
| Accrued Liabilities | $1M | $2M | $2M | $501.8K | $601.8K | $1M | $402.2K | $383.3K | $1M | $2M | $692.0K | $1M | $699.2K | $894.6K | $670.7K | $311.6K | |
| Short-term Debt | $5M | $6M | $3M | $5M | $4M | $3M | · | · | · | $3M | $3M | $8M | $5M | $5M | $5M | · | |
| Current Liabilities | $9M | $10M | $6M | $7M | $6M | $5M | $2M | $2M | $2M | $10M | $6M | $11M | $7M | $7M | $6M | $923.5K | |
| Capital Leases | $968.5K | $1M | $1M | $1M | · | · | · | · | $33.1K | $130.7K | $225.4K | $317.3K | $405.5K | $488.7K | $578.6K | $665.8K | |
| Total Liabilities | $10M | $13M | $7M | $8M | $7M | $7M | $2M | $2M | $2M | $10M | $6M | $11M | $7M | $8M | $7M | $2M | |
| Total Debt | $5M | · | $3M | $5M | $4M | · | · | · | · | · | $3M | $8M | $5M | · | $5M | · | |
| Common Stock | $1.4K | $725 | $596 | $488 | $382 | $340 | $305 | $78 | $502 | $10 | $1.7K | $1.2K | $1.1K | $61 | $1.1K | $1.1K | |
| Paid-in Capital | $171M | $135M | $130M | $123M | $118M | $117M | $114M | $102M | $99M | $86M | $86M | $74M | $73M | $73M | $73M | $73M | |
| Retained Earnings | $-148M | $-132M | $-126M | $-117M | $-112M | $-110M | $-102M | $-99M | $-96M | $-93M | $-86M | $-80M | $-73M | $-69M | $-65M | $-61M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3.2K | |
| Stockholders' Equity | $23M | $3M | $3M | $6M | $6M | $7M | $12M | $3M | $3M | $-7M | $-96.3K | $-6M | $81.6K | $4M | $8M | $12M | |
| Liabilities + Equity | $33M | $15M | $11M | $13M | $12M | $15M | $14M | $5M | $5M | $3M | $6M | $5M | $7M | $11M | $15M | $14M | |
| Shares Outstanding | 13,894,882 | 7,250,299 | 5,977,358 | 4,889,290 | 3,826,199 | 3,402,306 | 3,044,165 | 780,762 | 5,010,470 | 97,293 | 17,378,798 | 12,056,788 | 11,309,412 | 602,640 | 11,309,412 | 11,309,412 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $362.2K | $386.0K | $592.8K | $187.4K | $357.6K | $60.3K | $393.8K | $376.8K | $164.6K | $154.6K | $236.3K | $217.4K | $204.5K | $206.4K | $205.7K | $207.2K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | $0 | |
| Operating Cash Flow | $-6M | $-4M | $-4M | $-5M | $-5M | $-4M | $-4M | $-2M | $-9M | $-3M | $-4M | $-5M | $-4M | $-4M | $-3M | $-4M | |
| CapEx | $67.1K | $156.2K | $0 | · | · | $198.5K | $-140.8K | $72.6K | $81.5K | $187.0K | $0 | $1 | $37.1K | $143.0K | $0 | $0 | |
| Investing Cash Flow | $-67.1K | $-156.2K | $0 | · | · | $-198.5K | $140.8K | $-72.6K | $-81.5K | $-187.0K | $0 | $-1 | $-37.1K | $-143.0K | $3.2K | $-2.5K | |
| Stock Issued | $9M | $3M | $1M | $4M | $2M | $1M | $13M | $1M | $10M | $819.5K | $6M | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $2M | · | · | · | $10M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $9M | $1M | $4M | $2M | $6M | $13M | $1M | $10M | $815.4K | $6M | $3M | $-3.9K | $-89.8K | $5M | $-3.7K | |
| Net Change in Cash | $3M | $5M | $-3M | $-618.8K | $-3M | $2M | $10M | $-732.9K | $1M | $-2M | $2M | $-1M | $-4M | $-4M | $2M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-9M | · | · | · | $-4M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3909.4% | · | · | 3395.9% | 3829.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 4238.1% | · | · | 3497.2% | 3929.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 4238.1% | · | · | 3497.2% | 3929.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 3909.4% | · | · | 3395.9% | 3829.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -25.2% | · | -60.9% | -51.5% | -42.3% | · | -33.2% | -62.0% | -47.0% | · | -56.3% | -69.5% | -31.3% | · | -52.4% | -58.5% | |
| ROE | -40.5% | · | -94.7% | -111.4% | -83.2% | · | -54.1% | 212.9% | -180.3% | · | -144.6% | -217.4% | -49.8% | · | -96.3% | -66.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | · | 1.3 | 1.5 | 1.9 | · | 7.4 | 1.2 | 1.2 | · | 0.5 | 0.2 | 0.6 | · | 1.8 | 10.9 | |
| Quick Ratio | 3.3 | · | 1.0 | 1.3 | 1.7 | · | 6.5 | 1.0 | 0.5 | · | 0.3 | 0.0 | 0.3 | · | 1.5 | 8.9 | |
| Debt / Equity | 0.2 | · | 0.9 | 0.9 | 0.7 | · | · | · | · | · | -31.1 | -1.3 | 61.3 | · | 0.6 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -94.3 | · | -24.2 | -25.2 | -20.5 | · | -37.9 | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.0 | · | · | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.69 | · | $0.58 | $1.13 | $1.55 | · | $3.95 | $3.95 | $0.64 | · | $-0.01 | $-0.51 | $0.01 | · | $0.74 | $1.08 | |
| Revenue / Share | $-0.01 | · | · | $-0.03 | $-0.03 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | · | · | $-1.26 | · | · | · | $-1.77 | · | · | · | · | · | · | · | |
| Cash / Share | $2.04 | · | $1.02 | $1.82 | $2.49 | · | $3.30 | $0.49 | $0.22 | · | $0.11 | $0.03 | $0.15 | · | $0.87 | $0.72 | |
| EPS (TTM) | $-3.71 | · | $0.61 | $-0.38 | $-4.71 | · | $-240.54 | $-310.80 | $-312.12 | · | $-114.66 | $-42.42 | $-35.99 | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-29M | · | $-22M | $-19M | $-17M | · | $-17M | $-19M | $-23M | · | $-21M | $-19M | $-17M | · | $-16M | $-27M | |
| Market Cap | $835.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $-23M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -6173.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı % | 1464.8% | · | · | · | · |
| Net Gelir | $-22M | $-17M | $-24M | $-18M | $-21M |
| Seyreltilmiş Hisse Başı Kâr | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 2.5 | 0.3 | -0.4 | 1.3 | · |
| Cari Oran | 1.2 | 2.5 | 0.1 | 1.1 | 16.0 |
| Cari Oran | 1.1 | 2.5 | 0.0 | 0.8 | 14.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-17M | $-19M | $-15M | $-16M | $-11M |
Kurumsal Sahipler (13F) 8 dosya · $2K toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
8
Tutulan Değer
$2K
Yeni pozisyonlar
6
Çıkan pozisyonlar
2
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (+4 önceki Ç'ye göre) | 2 (+1 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | 0 (-1 önceki Ç'ye göre) | +94K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | $672 | 35.200 | 36,60% | Hisse senetleri |
| MAI Capital Management | $497 | 26.021 | 27,07% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $441 | 23.080 | 24,02% | Hisse senetleri |
| TWO SIGMA SECURITIES, LLC | $209 | 10.918 | 11,38% | Hisse senetleri |
| GoalVest Advisory LLC | $15 | 3.000 | 0,82% | Hisse senetleri |
| TORONTO DOMINION BANK | $2 | 100 | 0,11% | Hisse senetleri |
| HRT FINANCIAL LP | $0 | 13.224 | 0,00% | Hisse senetleri |
| Virtu Financial LLC | $0 | 12.626 | 0,00% | Hisse senetleri |
Şirket yöneticileri 12 içeriden öğrenenler · 7 yöneticiler · 6 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Shane J. Schaffer | Chief Executive Officer | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Jennifer L. Callahan | EVP and CFO | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Laurie Myers | EVP and COO | 07 Temmuz 2025 A | · | 0 | 0 | $0 |
| Raul R. Silva | EVP and CSO | 30 Eylül 2026 A | · | 0 | 0 | $0 |
| Bryan Wade Downey | EVP & Chief Commercial Officer | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Matthew Brams | EVP and Chief Medical Officer | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Nilay Dahyabhai Patel | CLO and CCO | 08 Temmuz 2025 A | · | 0 | 0 | $0 |
| Bryan Jay Lawrence | Yönetim kurulu üyesi | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Peter J. Werth | Yönetim kurulu üyesi | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Thomas Jeffrey Hargroves | Yönetim kurulu üyesi | 16 Temmuz 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Ervin | Yönetim kurulu üyesi | 20 Haziran 2025 A | · | 0 | 0 | $0 |
| John A Roberts | Yönetim kurulu üyesi | 20 Haziran 2025 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026